Navigation Links
DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
Date:4/1/2008

EL SEGUNDO, Calif., April 1, 2008 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease, today announced its former Chief Medical Officer (CMO) Charles J. McAllister, M.D. will retire effective April 1, 2008. Dr. McAllister stepped down as CMO in July 2007, and has since served as CMO emeritus in the Office of the CMO.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

"Charlie has provided 30 years of incredible service to kidney care patients and the broader kidney care community, as a practicing nephrologist, as a hospital chief of staff and as DaVita's chief medical officer," said DaVita CEO Kent Thiry. "The combination of his energy, his intellect, his sense of humor and his warm bedside manner is amazing."

Dr. McAllister served as CMO for DaVita(R) since 2000. During that time, his dedication to continuous improvement in the areas of physician performance management, national clinical measurement development, product evaluation and testing, and clinical compliance program implementation, among others, helped DaVita become a national leader in clinical outcomes. Dr. McAllister's efforts also helped shaped DaVita's community-like work environment, which has been broadly written about and is taught at many major business schools.

"Dr. McAllister really represents the life-force of the Physician Council at DaVita, serving as DaVita's physician beacon of outstanding and compassionate care for our most vulnerable patients," said John Robertson, M.D. "All of the physicians remaining with the Office of the Chief Medical Officer will continue to aspire to the same level of professionalism and integrity that Charlie single handedly inspired since the day he joined with DaVita."

Prior to serving as CMO for DaVita, Dr. McAllister served as vice president of m
'/>"/>

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NxStage Medical Announces Needle Supply Agreement with DaVita
2. DaVita to Present at UBS Best of Americas Conference
3. Human Pheromone Sciences Announces Quarterly and Full Year Results
4. Dragon Pharma announces 2007 full year financial results
5. Genaera Corporation Announces 2007 Financial Results
6. Genmab Announces Year End 2007 Financial Results
7. Immunosyn Corporation Announces 2007 Results, Files 10KSB
8. Elbit Imaging Ltd. Announces Results For Fiscal Year 2007
9. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
10. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
11. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), today announced ... from sales of Thalomid® during the third quarter ... In addition, the Company anticipates a decrease ... 2009. The difference in estimated and actual ... in the fourth quarter financial results. ,, (Logo: ...
(Date:12/11/2009)... Boston College researchers have observed the "hot electron" effect ... successfully harvested the elusive charges using ultra-thin solar cells, ... the authors report in the current online edition of ... captured in solar cells, it generates free electrons in ... snare these charges, the electrons must reach the bottom ...
(Date:12/11/2009)... 11 Gwathmey, Inc., a pre-clinical contract ... staph aureus, and cardiovascular disease announces a new ... that Rosalie Dunn, Ph.D., has joined Gwathmey as ... 28 years of experience working with small businesses ... Gwathmey, Dr. Dunn managed multimillion dollar portfolios for ...
(Date:12/10/2009)... N.C., Dec. 10 Microban International, ... product protection, has partnered with Sharp Imaging ... of Sharp Electronics, to incorporate it,s third ... printing calculators. Infused into the calculator keys ... inhibits the growth of damaging bacteria on ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2
... of Farletuzumab for Ovarian CancerAgreement Highlights Lonza,s Ability ... and BASEL, Switzerland, May 19 Morphotek(R), Inc., ... and Lonza Group Ltd jointly announced today that ... support the development and manufacturing of a subset ...
... SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture ... today reported encouraging data from the Company,s Apo ... show that SemBioSys, plant-derived Apo AI(Milano) has exhibited ... reduce overall plaque volume. , New data from ...
... to Sustainable Innovation., Accelerates LS9,s Entry into the Consumer ... ... San Francisco, CA (PRWEB) -- LS9, Inc., the Renewable Petroleum ... Gamble (NYSE: PG), one of world,s largest consumer products companies. ...
Other Biology Technology:Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 2Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 3Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 4SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 2SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 3SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 4LS9 and Procter & Gamble Launch Sustainable Chemicals Partnership 2
(Date:12/14/2009)... of the United Nations Framework Convention on Climate ... Agency hosted the ,Bend the Trend, event on ... platform and premiere the screening of the new ... of Europe, a joint project of the European ... and ESA, is a series of short films ...
(Date:12/14/2009)... As good as laparoscopy is in preventing some of the ... drawbacks, including reduced blood flow and organ dysfunction. Laparoscopy is ... incisions. , By adding another gas ... during laparoscopy, researchers at Duke University Medical Center have found ... , The gas ethyl nitrite (ENO) helped to open ...
(Date:12/13/2009)... a popular class of drugs used to treat ... components of chemical communication in the brain. ... people with schizophrenia also struggle to sustain attention ... that interfere with their ability to hold a ... student in the medical scientist training program at ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Gas improves blood flow and organ status during minimally invasive surgery 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Nicotine Patch Plus Lozenge Best for Quitting Smoking 60533 1Nicotine Patch Plus Lozenge Best for Quitting Smoking 60533 2Nicotine Patch Plus Lozenge Best for Quitting Smoking 60533 3Precuneus region of human and monkey brain is divided into 4 distinct regions 60531 1Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 1Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 2
... recent killer tsunami has highlighted once more the ... function is taken up by mangroves, forests thriving ... are ecologically and socio-economically important for local people ... geography, hydrology, socio-economic interviews, and 18th-century history, an ...
... growing older are as,inevitable and obvious as “going ... cause of this usually unwelcome transformation.,In a report ... journal Science,researchers from Dana-Farber Cancer Institute and Children’s ... of graying hair while,investigating the origins of malignant ...
... to fully understand a particular communication pathway inside of ... cancers. While scientists have identified elements of this pathway, ... Whitehead Institute now have discovered a missing puzzle piece, ... significant new cancer target. , "We believe that we ...
Other Biology News:Essential mangrove forest threatened by cryptic ecological degradation 2Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 2Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 3Researchers identify target for cancer drugs 2
Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
... loxP-PGK-gb2-neo-loxP template is designed to allow ... cells. The loxP-PGK-gb2-neo-loxP template encodes ... a prokaryotic promoter (gb2) for expression ... a eukaryotic promoter (PGK) for expression ...
... These precision 5mm diameter, 7 inch long PYREX ... for compatibility with ground joints, valves, and vacuum ... spectrometers running from 300 to 500MHz. They have ... I.D. of 4.20 + 0.013-0.000mm. These NMR tubes ...
Biology Products: